Why Investing In The Greek Cannabis Market Is So Tempting
Marguerite Arnold
March 26th, 2018
Policy
There are several markets in the world right now which should be on the scopes of international investors who want a little canna flair to their portfolio. For the most part, the safest part of the market is the international (at least to Americans) medical cannabis vertical, precisely because it is going to be so regulated. Want a green, feel good, pro-medical investment in your (institutionally backed) portfolio? Euro, Canadian, Israeli, and Australian markets are all interesting bets right now.
However there is one place that promises, for a variety of reasons, to be a hybrid from the get-go, and further backed with an enthusiasm, from a federal government, so far unseen anywhere else in the world.
For that reason, outside of Germany, there are few markets in the world this spring that have as much potential as the Greek medical cannabis market.
The country is opening its arms to foreign investment of the medical cannabis kind.
Combined with tourism, which is on the rise, and the conditions are perfect for a Mediterranean cannabis industry which not only caters to an influx of visitors already but for whom this would only be the added icing on the cake.
Think Nevada (the first state with reciprocal medical rights for tourists). Or even California, except this time with federal rights. Not even Canada (or Israel for that matter) potentially has been so opening to this kind of investment – although both are certainly opening their arms to it now. For Europeans, think Spain, with federal reform and active encouragement. Or Germany with the attitude of the Swiss and a cannabis that contains THC.
For all these reasons, Greece is also another possibility altogether.
Why?
The Federal Government Is Actively Investing In This Sector
In northern Greece, in a place called Veroia, between 2-3,000 jobs are about to come out of a really unique experiment. Golden Greece, a company responsible for coordinating the projects group of 10 investors from Canada, Kazakhstan, Poland and Israel, has invested about $500 million so far, with an expected goal of close to $2 billion. The company (and others like them) are also operating with the explicit help and support of the government.
80% of those jobs will be going to Greeks. And as such, already a great example of how a thriving industry here will prove to be a vital tool of economic stabilization for a country.
Average monthly wages hover around $700, some of the lowest in the EU. Top earners in the cannabis industry can bring home between $80-100k per year, even here.
Even better? The Greek government is also not shy about its intentions to expand into recreational – when the time is right. As seen elsewhere, the medical market is the first to open any new jurisdiction. It took Canada four years to make the transition. Given the flavor of local politics in the EU, it will probably take that long here too. But look at Canada now.
The Impact On The Rest Of Europe
One of the fundamentally more interesting impacts, besides creating an even “buzzier” tourist economy (which is already trending up again, including from German visitors), is the impact Greek green business development will have across the continent. Right now, it is beginning, particularly with the promise of foreign investment attached. That is true across Europe. For the most part, officials are also cautiously optimistic but asking for referrals and the normal business credentials. That includes verification of liquidity and other standard business norms (like background checks for officers of public companies).
In Greece, as in other places, the people getting in the door now are, for the most part, accredited investors only. But that, in turn, will seed a much broader, greener, economy that will allow smaller investors, and even more interestingly, investment funds, to enter the market here in a way unlike most of Europe for now. However, the inevitable success of those smaller models will also absolutely seed the cause for greater and wider reform. Not just in Greece, but across Europe.
For all the reluctance of politicians, Europe is going to have a very verdant and lush canna spring!
For one of the best entries into this market from a business perspective, be sure also to go to the ICBC Berlin, April 11-13. Early bird pricing still applies.
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
About Marguerite Arnold
Marguerite Arnold is a veteran investigative and markets journalist, American expat and author. She has covered the cannabis industry from Germany for the last six years. Her book, Green: The First Year of Modern American Cannabis Reform about the American market in 2014 has just been republished as she is writing the sequel about Europe and the global revolution this year. Green II: Spreading Like Kudzu will be published in 2020. She is also a noted technologist and entrepreneur. Her blockchain-based digital prescription platform MedPayRx was just shortlisted by the German Ministry of Health as one of the "Top 20" use cases for blockchain in healthcare.
Search CannabisFN
Press Coverage
Psychedelics Index
Top Videos
Watch CFN Media’s exclusive three part interview with Paul Rosen, one of the most active and diversified investors in the emerging cannabis industry. Paul gives his insights on the global cannabis industry and discusses his new endeavors. Become a CFN Media Client Paul Rosen is a noted career entrepreneur and management consultant. Over the last […]
Tim has over 22 years of investment experience as a portfolio manager, asset allocator, and capital markets professional across multiple asset classes, geographies, and platforms. Tim has built and operated two hedge funds, a broker dealer, and raised over $1Bn in capital for his combined businesses. Tim remains a recognized voice within the investment community […]
Creso was created to bring pharmaceutical expertise and methodological rigour to the world of cannabis and deliver quality products to people and animals everywhere.
Headquartered in Calgary, Canada , Willow and its team of scientists are leaders in the field of biosynthetic production of high value plant-derived compounds.
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer
